67 results
8-K
EX-4.1
CRVS
Corvus Pharmaceuticals Inc
6 May 24
Entry into a Material Definitive Agreement
4:11pm
exercise of this Warrant shall be made without charge to the Holder for any issue or transfer tax, transfer agent fee or other incidental tax … by the Company; provided, however, that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved
8-K
EX-10.1
CRVS
Corvus Pharmaceuticals Inc
6 May 24
Entry into a Material Definitive Agreement
4:11pm
of any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.
(cc) Tax … , the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise tax
8-K
EX-4.2
CRVS
Corvus Pharmaceuticals Inc
6 May 24
Entry into a Material Definitive Agreement
4:11pm
charge to the Holder for any issue or transfer tax, transfer agent fee or other similar incidental tax or expense (excluding any applicable stamp … , that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the registration of any certificates for Warrant
424B5
4e4oeg0
3 May 24
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
kyi6838zsho 9z77771v
19 Mar 24
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:02pm